132 related articles for article (PubMed ID: 22175303)
1. KIT and BRAF mutational status in a patient with a synchronous lentigo maligna melanoma and a gastrointestinal stromal tumor.
Matin RN; Gonzalez D; Thompson L; Lambert SR; Bakr F; Dhomen N; Marais R; McGregor JM; Szlosarek P; Cerio R; Harwood CA
Am J Clin Dermatol; 2012 Feb; 13(1):64-5. PubMed ID: 22175303
[No Abstract] [Full Text] [Related]
2. The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.
Stadelmeyer E; Heitzer E; Resel M; Cerroni L; Wolf P; Dandachi N
J Invest Dermatol; 2014 Feb; 134(2):548-550. PubMed ID: 24026210
[No Abstract] [Full Text] [Related]
3. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
Lang J; MacKie RM
J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
[TBL] [Abstract][Full Text] [Related]
4. Braf-V600e immunohistochemical analyses in a series of 15, Caucasian patients affected by lentigo maligna.
Dika E; Lambertini M; Fanti PA; Scarfì F; Corti B; Altimari A; Ceccarelli C; Pesci S; Evangelista V; Patrizi A
Acta Histochem; 2019 Apr; 121(3):380-381. PubMed ID: 30797564
[No Abstract] [Full Text] [Related]
5. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
7. [Melanoma and search for therapeutic targets].
de la Fouchardière A
Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449
[No Abstract] [Full Text] [Related]
8. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
9. Relationship between DNA ploidy-related parameters and the deletions in mismatch repair genes MLH1 and MSH2 in lentigo maligna and malignant melanomas.
Korabiowska M; Viehöver M; Schlott T; Berger H; Droese M; Brinck U
Arch Dermatol Res; 2001 May; 293(5):219-25. PubMed ID: 11409565
[TBL] [Abstract][Full Text] [Related]
10. Lentigo Maligna.
Franke JD; Woolford KM; Neumeister MW
Clin Plast Surg; 2021 Oct; 48(4):669-675. PubMed ID: 34503727
[TBL] [Abstract][Full Text] [Related]
11. BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
Jašek K; Váňová B; Grendár M; Štanclová A; Szépe P; Hornáková A; Holubeková V; Plank L; Lasabová Z
Pathol Res Pract; 2020 Nov; 216(11):153171. PubMed ID: 32836055
[TBL] [Abstract][Full Text] [Related]
12. Synchronous conjunctival melanoma and lentigo maligna melanoma.
Volpini BMF; Maia M; Agi J; Vital J; Lellis RF
An Bras Dermatol; 2017; 92(4):565-567. PubMed ID: 28954115
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum and lentigo maligna in identical twins.
Faghihi G; Radan M
J Dermatolog Treat; 2006; 17(4):241-3. PubMed ID: 16971321
[TBL] [Abstract][Full Text] [Related]
14. May melanophages hinder the subclinical spread of lentigo maligna and lentigo maligna melanoma? Results from a pilot study.
Moro R; Requena C; Ríos-Viñuela E; Manrique-Silva E; Traves V; Calzavara-Pinton PG; Gualdi G; Nagore E
J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e365-e367. PubMed ID: 33462879
[No Abstract] [Full Text] [Related]
15. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
[TBL] [Abstract][Full Text] [Related]
16. Molecular Profile of Gastrointestinal Stromal Tumors in Sixty-Eight Patients from a Single Swiss Institution.
Haefliger S; Marston K; Juskevicius D; Meyer-Schaller N; Forster A; Nicolet S; Komminoth P; Stauffer E; Cathomas G; Hoeller S; Tornillo L; Dirnhofer S; Terracciano LM; Bihl M; Matter MS
Pathobiology; 2020; 87(3):171-178. PubMed ID: 32079019
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal Stromal Tumor.
Guo R; Erickson LA
Mayo Clin Proc; 2019 Feb; 94(2):373-374. PubMed ID: 30711139
[No Abstract] [Full Text] [Related]
18. Lentigo maligna and lentigo maligna melanoma.
Dallimore KJ
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):500. PubMed ID: 9091498
[No Abstract] [Full Text] [Related]
19. TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
Diaz A; Puig-Butillé JA; Muñoz C; Costa D; Díez A; Garcia-Herrera A; Carrera C; Badenas C; Solé F; Malvehy J; Puig S; Alos L
J Am Acad Dermatol; 2014 Oct; 71(4):839-41. PubMed ID: 25219713
[No Abstract] [Full Text] [Related]
20. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma.
Schultz BC; Roenigk HH
J Am Acad Dermatol; 1998 Sep; 39(3):519. PubMed ID: 9738802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
